Santos-Ocampo C D, Herman S D, Travin M I, Garber C E, Ahlberg A W, Messinger D E, Heller G V
Nuclear Cardiology Laboratory, Memorial Hospital of Rhode Island, Pawtucket 02860, USA.
J Nucl Cardiol. 1994 Jan-Feb;1(1):57-64. doi: 10.1007/BF02940012.
Pharmacologic stress has been shown in animal studies to induce high degrees of myocardial hyperemia. At these levels of myocardial blood flow, the myocardial uptake of technetium 99m sestamibi may plateau and may affect the diagnostic accuracy. This study compared the effects of myocardial hyperemia induced by exercise, dipyridamole, and adenosine on 99mTc sestamibi tomographic imaging in normal subjects and patients with ischemic coronary artery disease.
Twenty subjects (group I, 10 normal subjects; group II, 10 patients with known coronary artery disease) underwent 99mTc sestamibi tomographic imaging after rest, exercise, dipyridamole infusion, and adenosine infusions on separate occasions. Total and background-corrected myocardial counts of the resulting images were calculated. Visual and computer-generated quantitative myocardial perfusion defect analysis was performed in subjects in group II. For subjects in both groups I and II, there were no significant differences in the background-corrected myocardial counts obtained with exercise, dipyridamole, and adenosine stress. There were no significant differences in the myocardial perfusion defects obtained after the three different modes of stress, including percentage defect size, stress deficit percentage, percentage of ischemia, count deficit index, and defect nadir.
The myocardial uptake of 99mTc sestamibi in normal subjects and patients with coronary artery disease is comparable after exercise, dipyridamole, and adenosine stress. In addition, the defect sizes and intensities with 99mTc sestamibi after all forms of stress were equivalent. Thus 99mTc sestamibi, in combination with either adenosine or dipyridamole infusions, provides imaging data equivalent to those with exercise and may be considered an alternative in patients unable to undergo adequate exercise.
动物研究表明,药物负荷可诱导高度的心肌充血。在这些心肌血流水平下,锝99m甲氧基异丁基异腈的心肌摄取可能会达到平台期,并可能影响诊断准确性。本研究比较了运动、双嘧达莫和腺苷诱导的心肌充血对正常受试者和缺血性冠状动脉疾病患者99mTc甲氧基异丁基异腈断层显像的影响。
20名受试者(I组,10名正常受试者;II组,10名已知冠状动脉疾病患者)在不同时间分别进行静息、运动、双嘧达莫输注和腺苷输注后接受99mTc甲氧基异丁基异腈断层显像。计算所得图像的总心肌计数和背景校正后的心肌计数。对II组受试者进行视觉和计算机生成的定量心肌灌注缺损分析。对于I组和II组的受试者,运动、双嘧达莫和腺苷负荷后获得的背景校正心肌计数无显著差异。三种不同负荷模式后获得的心肌灌注缺损,包括缺损大小百分比、负荷缺损百分比、缺血百分比、计数缺损指数和缺损最低点,均无显著差异。
运动、双嘧达莫和腺苷负荷后,正常受试者和冠状动脉疾病患者的99mTc甲氧基异丁基异腈心肌摄取相当。此外,所有负荷形式后99mTc甲氧基异丁基异腈的缺损大小和强度相当。因此,99mTc甲氧基异丁基异腈联合腺苷或双嘧达莫输注可提供与运动相当的显像数据,对于无法进行充分运动的患者可考虑作为替代方法。